根据提交至美国证券交易委员会（SEC）的一份文件披露，INVO Fertility公司的审计委员会已发出明确警示，指出该公司2025年第一季度、第二季度及第三季度的财务报表不应被依赖。
这意味着，投资者在评估INVO Fertility这段时间内的财务状况和经营业绩时，需对已公布的财务数据持高度审慎态度。审计委员会的这一声明，通常指向财务报告可能存在重大错报或内部控制缺陷，需待进一步审查或重述。
该消息无疑为市场投下了一枚震撼弹，可能引发对公司治理、财务透明度以及未来合规进程的广泛关注与质疑。后续进展值得密切关注。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.